Patient-centric clinical trials represent a transformative approach in the realm of medical research, placing the needs and perspectives of patients at the forefront. Emphasizing collaboration and engagement, these trials aim to enhance the overall patient experience, ensuring their voices are heard in the development and execution of research protocols. In patient-centric trials, there is a conscious effort to streamline participation processes, reducing burdens on patients while maximizing the collection of meaningful data. Transparent communication, simplified consent procedures, and accessible trial information contribute to fostering a sense of empowerment and understanding among participants.
The integration of patient input in study design and endpoint selection contributes to the relevance and effectiveness of clinical trials. Patient-centricity extends beyond data collection to encompass the overall well-being of participants, recognizing their unique needs and challenges throughout the trial journey. Patient-centric clinical trials embody a paradigm shift, aligning with the principles of personalized medicine and recognizing the individuality of each patient. As this approach gains prominence, it not only promotes greater patient satisfaction but also contributes to more robust and applicable research outcomes.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia